(Q37060588)

18 August 2017

1 reference

title

Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification (English)

1 reference

18 August 2017

0 references

arterial hypertension

0 references

author name string

Mirjam E van Albada

series ordinal

1

1 reference

18 August 2017

Rolf M F Berger

series ordinal

2

1 reference

18 August 2017

publication date

21 January 2008

1 reference

18 August 2017

published in

Cardiology in the Young

1 reference

18 August 2017

volume

18

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

10-17

1 reference

International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Eisenmenger syndrome. Factors relating to deterioration and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Endothelin-1 in congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Long-term hemodynamic effects of nifedipine on congenital heart disease with Eisenmenger's mechanism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Pulmonary thrombosis in adults with Eisenmenger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Pulmonary vascular disease in adults with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Heart-lung or lung transplantation for Eisenmenger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

The Fontan circulation: a challenge to William Harvey?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

How to manage the Eisenmenger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Elucidation of the natural history of ventricular septal defects by serial Doppler color flow mapping studies

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

The pulmonary circulation and congenital heart disease. Considerations of the role of the pulmonary circulation in certain systemic-pulmonary communications

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Pulmonary vascular resistance during exercise late after repair of large ventricular septal defects. Relation to age at the time of repair

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Natural history and prognosis of atrial septal defect

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Severe pulmonary hypertension associated with a small ventricular septal defect

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

Assessment of survival benefit after lung transplantation by patient diagnosis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

https://api.crossref.org/works/10.1017%2FS1047951107001849

1 reference

7 January 2021

Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects

1 reference

https://api.crossref.org/works/10.1017%2FS1047951107001849

7 January 2021

10.1017/S1047951107001849

Identifiers

DOI

1 reference

18 August 2017

1 reference